Predictors of Poor Outcomes in Monochorionic Diamniotic Twin Pregnancies Complicated by Selective Fetal Growth Restriction
Fetal Diagnosis and Therapy · 2024
DOI: 10.1159/000537861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2024. Verfasst von Shelly Soni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Richard D. Wood Jr Center for Fetal Diagnosis and Treatment, Department of General, Thoracic and Fetal Surgery, Children's Hospital of Philadelphia, …. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Pregnancy, Twin, Ultrasonography, Prenatal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
The aim of the study was to identify predictors of poor outcomes in monochorionic diamniotic twin (MCDA) pregnancies with selective fetal growth restriction (sFGR), irrespective of the umbilical artery (UA) Doppler abnormalities.
Methods
Single-center retrospective analysis of MCDA twins diagnosed with sFGR that opted for expectant management between 2010 and 2021. The presence of any of the following variables in the growth-restricted fetus: low amniotic fluid volume (DVP ≤2 cm), lack of a cycling bladder, absent or reversed flow in the ductus venosus (DV) with atrial contraction, and elevated middle cerebral artery peak systolic velocity (MCA-PSV) defined as ≥1.50 multiples of the median was categorized as complicated. sFGR cases were classified as simple in the absence of the above-mentioned variables.
Results
Overall, 63.3% of cases qualified as simple, and 36.7% were complicated. Intertwin EFW discordance was higher in the complicated category (26 vs. 33%, p = 0.0002). The median gestational age at delivery was earlier (33 weeks vs. 30.5 weeks, p = 0.002), and the likelihood of survival was lower in the complicated category (p < 0.0001). The likelihood of two survivors to discharge was lower in type I complicated cases (70% in complicated type I vs. 97.1% in simple type I, p = 0.0003). On logistic regression analysis, an increase in the “complicated” score negatively correlated with two survivors to discharge (p < 0.0001). An ROC curve was created, and the AUC was 0.79. Increasing intertwin EFW discordance also decreased the probability of two survivors to discharge.
Conclusion
The presence of oligohydramnios, lack of a cycling bladder, abnormal DV Doppler, and elevated MCA-PSV in the growth restricted fetus is associated with poor perinatal outcomes and a lower likelihood of having two survivors to discharge. The addition of intertwin EFW discordance to these variables helped improve the survival predictability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Richard D. Wood Jr Center for Fetal Diagnosis and Treatment, Department of General, Thoracic and Fetal Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Soni, S., Gebb, J., Miller, K., Oliver, E. R., Teefey, C. P., Moldenhauer, J. S., & Khalek, N. (2024). Predictors of Poor Outcomes in Monochorionic Diamniotic Twin Pregnancies Complicated by Selective Fetal Growth Restriction. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000537861
Vancouver
Soni S, Gebb J, Miller K, Oliver ER, Teefey CP, Moldenhauer JS, et al. Predictors of Poor Outcomes in Monochorionic Diamniotic Twin Pregnancies Complicated by Selective Fetal Growth Restriction. Fetal Diagnosis and Therapy. 2024. doi:10.1159/000537861
BibTeX
@article{Soni2024,
author = {Soni, Shelly and Gebb, Juliana and Miller, Kendra and Oliver, Edward R and Teefey, Christina Paidas and Moldenhauer, Julie S and Khalek, Nahla},
title = {Predictors of Poor Outcomes in Monochorionic Diamniotic Twin Pregnancies Complicated by Selective Fetal Growth Restriction},
journal = {Fetal Diagnosis and Therapy},
year = {2024},
doi = {10.1159/000537861}
}
EUVIMED